RCT in Iran showing shorter time to clinical recovery with Ivermectin.
Results are from: 
Trial details:  (double blind according to the trial registration)
Rezai et al., 1/19/2021, Double Blind Randomized Controlled Trial, Iran, Middle East, preprint, 1 author, dosage 200μg/kg single dose.
recovery time, 21.2% lower, relative time 0.79, p = 0.02, treatment 51, control 52.
hospitalization time, 17.9% lower, relative time 0.82, p = 0.01, treatment 51, control 52.
Effect extraction follows pre-specified rules
prioritizing more serious outcomes. For an individual study the most serious
outcome may have a smaller number of events and lower statistical signficance,
however this provides the strongest evidence for the most serious outcomes
when combining the results of many trials.